EXPYDA Trademark

Trademark Overview

On Friday, March 16, 2012, a trademark application was filed for EXPYDA with the United States Patent and Trademark Office. The USPTO has given the EXPYDA trademark a serial number of 85571363. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 17, 2022. This trademark is owned by Glaxo Group Limited. The EXPYDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
expyda

General Information

Serial Number85571363
Word MarkEXPYDA
Filing DateFriday, March 16, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 17, 2022
Registration Number4861675
Registration DateTuesday, December 1, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "EXPYDA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, June 17, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, December 1, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 1, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 28, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, September 21, 2015NOTICE OF ALLOWANCE CANCELLED
Monday, September 21, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2015SOU EXTENSION 5 GRANTED
Monday, March 2, 2015SOU EXTENSION 5 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Tuesday, September 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 8, 2014SOU EXTENSION 4 GRANTED
Thursday, August 28, 2014SOU EXTENSION 4 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Friday, March 21, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 20, 2014SOU EXTENSION 3 GRANTED
Wednesday, March 12, 2014SOU EXTENSION 3 FILED
Wednesday, March 12, 2014TEAS EXTENSION RECEIVED
Tuesday, October 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2013SOU EXTENSION 2 GRANTED
Wednesday, September 18, 2013SOU EXTENSION 2 FILED
Wednesday, October 23, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 18, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2013SOU EXTENSION 1 GRANTED
Wednesday, February 27, 2013SOU EXTENSION 1 FILED
Wednesday, February 27, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 25, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 25, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 25, 2012DATA MODIFICATION COMPLETED
Monday, June 25, 2012ASSIGNED TO LIE
Saturday, June 23, 2012ASSIGNED TO EXAMINER
Monday, March 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

expyda pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological